OBJECTIVES: Recently, paravertebral block (PVB) has been reported to be an effective analgesic modality for post-thoracotomy pain, but there is no consensus on how thoracic PVB can be more effective. Our hypothesis that intact pleura has a significant impact on the analgesic effectiveness of thoracic PVB was evaluated.
INTRODUCTION
Post-thoracotomy pain, which is encountered frequently, can lead to a high incidence of pulmonary complications if it is not controlled appropriately [1] . Presently, several analgesic techniques are used to control post-thoracotomy pain; among these techniques, epidural block is the most common and is the gold standard [2, 3] . We introduced paravertebral block (PVB) for thoracic analgesia in April 2010 at our institution because of its simplicity and analgesic effectiveness [4] . Thoracic PVB was originally described by Sabanathan et al. [5, 6] , and they subsequently updated this technique by inserting an indwelling extrapleural catheter for continuous infusion of local anaesthetic (LA) postoperatively. The analgesic effectiveness of thoracic PVB has been validated by several studies [7] [8] [9] [10] [11] .
We conducted a retrospective analysis to prove our hypothesis that pleural integrity should be maintained during PVB catheterization for more effective thoracic analgesia.
MATERIALS AND METHODS
This study included patients who underwent general thoracic procedures for pulmonary and mediastinal lesions and subsequent PVB catheterization between April 2010 and March 2013. The study was approved by the Institutional Review Board (IRB) of Nagara Medical Center and the IRB waived the need for written consent from the patients. The confidentiality of information created as part of the data collection was strictly maintained.
LA is well distributed two to three interspaces above and below the level of the thoracotomy. We usually incise the parietal pleura down to the seventh or eighth intercostal space. Then, following lung reinflation before chest closure, administration of a LA is initiated through the PVB catheter, producing pleural tenting [4, 6] . Our PVB catheterization was performed by four surgeons, and each technique was quite identical in all patients analysed. We defined that intact pleura could contain administered LA well within the extrapleural space whereas disrupted pleura barely made pleural tenting with almost no LA accumulated extrapleurally.
In our study, the LA was administered as a 20-ml bolus of 0.5% bupivacaine (Marcain Plain; AstraZeneca, Osaka, Japan) until completion of the operation. Subsequently, we provided 6.0 ml/h of 1.0% lidocaine (Xylocaine; AstraZeneca, Osaka, Japan) through an infusion pump, or a 20-ml bolus of 0.375% ropivacaine, followed by the continuous administration of 6.0 ml/h of 0.2% ropivacaine (Anapeine; AstraZeneca, Osaka, Japan) in the same manner.
Every patient was strongly encouraged to take a painkiller without hesitation, if needed, to ensure a good cough effort and rigorous physiotherapy. An oral non-steroidal anti-inflammatory drug (NSAID, loxoprofen sodium hydrate, Loxonin 60 mg; Daiichi-Sankyo, Tokyo, Japan) was used to supplement the efficacy of PVB. Every postoperative patient was not allowed to take an NSAID tablet no <6 h apart, which indicated that the maximum frequency of NSAID use allowed was four times a day. In the case of analgesic failure with NSAIDs, intramuscular pentazocine (Pentagin 15 mg; Daiichi-Sankyo, Tokyo, Japan) was used as a rescue medication.
Propensity score matching
Prematch baseline characteristics were compared by bivariate analysis to assess imbalances of covariates. As an observational study, the occurrence of pleural disruption during PVB catheterization was not random since each surgeon tried to maintain pleural integrity. The pleural disruption (+) group and the (−) group may differ in variables that influence degree of analgesia. In an attempt to reduce the effect of potential bias, propensity score matching was used. Propensity scores were calculated by logistic regression analysis including the occurrence of pleural disruption as the response variable, and age, sex, body mass index (BMI), American Society of Anesthesiologists (ASAs) score, diagnoses, operative procedures including approach [ postero-lateral thoracotomy, anterior axillary thoracotomy or video-assisted thoracic surgery (VATS)], and intra-operative bleeding, operative time and local anaesthesia infused as explanatory variables. The estimated propensity score was then used to match 1:1 patients with similar propensity.
These data were collected retrospectively based on the chart review. Continuous variables are expressed as the mean (standard deviation). To assess the patients' demographic and perioperative variables, the χ 2 test with Yates' correction, when appropriate, was applied to compare the distributions of discrete variables, and the Student's t-test was used to compare metric variables. All tests were two-sided, and P-values <0.05 were considered significant. All statistical analyses were performed by using the R software packages, version 3.1.1. R is an open source project that is distributed under the GNU General Public License.
RESULTS

Prematched patient characteristics
For general thoracic procedures, 278 PVB catheterizations were performed; there were 82 patients with pleural disruption, and 196 patients without. The patient characteristics and operative data before matching are given in Table 1 . There were significant differences regarding age and ASA score between the groups.
Postmatched patient characteristics
The groups were well-matched with respect to multiple variables, including sex, age, BMI, ASA score, diagnoses, operative variables and LAs ( Table 2 ). The usage of rescue medication and the frequencies of NSAID use on postoperative days (PODs) 0-3 in both groups are also given in Table 2 . The comparison between both groups revealed that more patients with a pleural tear needed g M: 20-ml bolus of 0.5% bupivacaine and 6.0 ml/h of 1.0% lidocaine. R: 20-ml bolus of 0.375% ropivacaine and then 6.0 ml/h of 0.2% ropivacaine.
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And there was a statistical significance of the frequency of NSAIDs taken by patients with a pleura tear on POD1 (P < 0.001), though higher frequencies of NSAIDs use in patients with a pleural tear on POD2 and POD3 did not reach a statistical significance (P = 0.189 on POD2, and P = 0.462 on POD3). No respiratory complications related to poor analgesia by PVB were observed in either group. Patients with pleural disruption were more likely to suffer from postoperative nausea and vomiting than those without (P <0.001). Postoperative atrial fibrillation was noticed in 1 patient with pleural disruption and 3 patients without (Table 3) . Subgroup analysis showed those 4 patients with postoperative atrial fibrillation were given 20-ml bolus of 0.5% bupivacaine.
DISCUSSION
Inappropriately controlled post-thoracotomy pain, which often results in pulmonary complications such as atelectasis and pneumonia, delays the postoperative recovery of patients and leads to prolonged hospital stays [1, 12] . The use of an indwelling extrapleural catheter placed by the surgeons for continuous infusion of LA, that is, continuous PVB, has been shown to be at least as effective as the thoracic epidural block [4, 7, 11, 13, 14] .
Few studies have investigated the factors that have an influence on the effectiveness of thoracic PVB [15] . Kotze et al. [16] undertook a systematic review to determine the influence of several variables on the quality of post-thoracotomy analgesia provided by PVB. These authors stated three contributing factors: first, continuous infusion techniques are superior to intermittent bolus techniques; secondly, higher doses of LA can provide more effective analgesia than lower doses and; finally, bupivacaine and lidocaine are equally effective.
In comparison with a repeated intermittent technique, our continuous infusion of a LA for PVB would be up to nearly half a litre in 3 days in amount, which might be too much in fear of toxicity. A sub-pleural space created for PVB in our patients can contain 20 ml of a LA or less. And an extra amount of the LA was supposed to leak from that sub-pleural space. We stopped the LA infusion and removed the PVB catheter when postoperative chest tubes were taken out. Almost all of the patients received 2 days of PVB as given in Table 2 . And the LA leaking from the sub-pleural space was drained through a chest tube. Therefore, there should be a remote possibility of LA toxicity.
In our analysis, LA used via the PVB catheter was not the same in all patients. This might not be ideal in terms of study design. However, this has been addressed by using propensity score matching to analyse possible contributing factors including the choice of LA. Our result showed that the choice of a LA for PVB did not have a significant influence on analgesic effectiveness (Table 2) . And postoperative atrial fibrillation was noticed exclusively in patients who were given bupivacaine. Several reports support the safety and the analgesic effectiveness of ropivacaine as a LA for PVB [17, 18] . Considering the similar analgesic efficacies of some LAs (for example, bupivacaine and ropivacaine) and the reported cardiac-and as neuro-toxicity of bupivacaine [19] , ropivacaine should be recommended as a LA for thoracic PVB.
In terms of pharmacokinetics, Burlacu et al. [20] found that, following paravertebral administration of LAs, the maximum plasma i M: 20-ml bolus of 0.5% bupivacaine and 6.0 ml/h of 1.0% lidocaine. R: 20-ml bolus of 0.375% ropivacaine and then 6.0 ml/h of 0.2% ropivacaine.
concentration of the medications was within the safe range or was less than that of the effective levels after intravenous administration. Karmakar et al. [21] reported that sub-pleurally infused radioopaque contrast medium remained in the paravertebral space. Their findings strongly suggest that the analgesic effect exerted by PVB can be greatly attributed to a peripheral mechanism of action. In our study, as given in Table 2 , the incidence of analgesic failure with NSAIDs as well as the frequency of NSAIDs use on POD1 among the patients with pleural disruption was significantly higher than those without. This finding should well support the hypothesis that the disrupted pleura cannot contain the infused LA sub-pleurally, which is likely to diminish the analgesic effectiveness. Fagenholz et al. [22] also advocate the importance of an intact pleura when considering the adverse effects of PVB. These authors stated that, once the LA enters the pleural space through the pleural tears, the absorption of the LA from the pleural space is more rapid compared with that from the paravertebral space; this, in turn, might result in systemic toxicity, causing nausea and convulsion. Our study showed the higher incidence of postoperative nausea/vomiting in patients with pleural disruption (P <0.001), which could be well understood by the report by Fagenholz et al. [23] ; further, the total incidence of nausea was much lower compared with that reported for epidural block.
This study had several limitations. First, we did not use the visual analogue scale (VAS), which is the most commonly employed method for pain assessment [24] . As a substitute for VAS, we measured the degree of pain control according to the necessity of a rescue medication and the frequency of NSAIDs taken, as we previously described [4] . Secondly, our analysis was retrospective and observational without randomization.
In conclusion, creating a sub-pleural space without pleural disruption is essential for continuous thoracic PVB that is effective and safe.
